Thursday, March 26th5.9°C
25490
25546

Forest Labs buying specialty gastrointestinal and cystic fibrosis company Aptalis for $2.9B

NEW YORK, N.Y. - Forest Laboratories is buying Aptalis, which specializes in treatments for gastrointestinal problems and cystic fibrosis, for $2.9 billion in cash.

Shares of Forest Labs surged in premarket trading Wednesday.

Forest Labs President and CEO Brent Saunders said in a statement Wednesday that the transaction would help his company diversify its business. There's an anticipated $125 million in cost savings from the combination by 2016.

Forest Laboratories Inc. is buying the privately held Aptalis from its shareholders, which include private investment firm TPG.

Aptalis had $688 million in sales in fiscal 2013, which ended in September. Its top three U.S. products, Canasa, Carafate, and Zenpep, made up more than 60 per cent of its total 2013 sales. International sales comprised about 15 per cent of revenue. Third-party delivery technology provider and drug maker Aptalis Pharmaceutical Technologies accounted for about 15 per cent of revenue.

Forest Labs said that it plans to fund the deal with available cash and debt. The company said due to the acquisition it has not yet started its previously announced accelerated stock repurchase program. Forest Labs said that once it completes permanent financing for the buyout that it will consider starting the accelerated stock repurchase program.

The acquisition is expected to add about 78 cents per share to Forest Lab's 2015 adjusted earnings and almost $700 million in revenue.

The deal requires review by anti-trust authorities in the U.S. and Canada. The buyout is targeted to close in the first half of 2014.

Forest Labs' stock rose $5.89, or 10 per cent, to $64.65 in premarket trading about 1 1/2 hours before the market open.

The Canadian Press


Read more Business News

25596


Recent Trending




Today's Market
S&P TSX14869.80-59.57
S&P CDNX679.56+2.32
DJIA17678.23-40.31
Nasdaq4863.36-13.16
S&P 5002056.15-4.90
CDN Dollar0.7998-0.0012
Gold1204.90+7.60
Oil50.51-0.92
Lumber287.80+1.80
Natural Gas2.655-0.017

 
Okanagan Companies
Pacific Safety0.13+0.01
Knighthawk0.010.00
QHR Technologies Inc1.50+0.00
Cantex0.03-0.01
Anavex Life Sciences0.21+0.00
Metalex Ventures0.04-0.01
Russel Metals24.68-0.28
Copper Mountain Mining1.13+0.00
Colorado Resources0.115-0.010
ReliaBrand Inc0.0075-0.0004
Sunrise Resources Ltd0.045+0.000
Mission Ready Services0.235-0.005
Decisive Dividend Corporation1.78-0.32

 



24497

FEATURED Property
22164581105 3168 Via Centrale Road
2 bedrooms 2 baths
$249,900
more details
image2image2image2
Click here to feature your property
Please wait... loading


CRA Notice of Assessment

Many Canadians rush to file their taxes on time each year and don’t think about it until the next year. One of the most overlooked notices received from the CRA annually is the annual Notice of ...


Medical confidential?

If ICBC asks your doctor for your information you may wonder: Can ICBC ask my doctor for my medical information? Can ICBC request a medical report from my doctor without my consent? What is ICBC entit...


Stay out of sales limbo!

Have you ever had a series of good meetings with a prospect … gathered all kinds of information … and given what you thought was a great presentation … only to receive a response ...

_





25666


Member of BC Press Council


24222